Los estudios prospectivos de pacientes consecutivos con enfermedad tromboembólica venosa no identifican a todos los pacientes en riesgo. Análisis multicéntrico ambispectivo del grupo Contaminatep

Marín Barrera, L; Jara Palomares, L; Blasco Esquivias, I; Rodríguez Matute, C; Fernández Capitán, C; López Reyes, R; Bedate Díaz, P; García Fuika, S; García Lozaga, A; Lobo Beristain, JL; Rodríguez Dávila, MA; García Ortega, A; Andrés Quezada, C; Murga Arizabaleta, I; Otero Candelera, R.
Rev. esp. patol. torac ; 28(1): 29-37, ene. 2016. tab
Artículo en Español | IBECS (España) | ID: ibc-149674

Documentos relacionados

  1. Health-based risk neutralization in private disability insurance.
  2. Comorbidity Assessment Is Uneven Across Veterans Health Administration and Medicare for the Same Patient: Implications for Risk Adjustment.
  3. Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries.
  4. The Impact of Pharmacy-specific Predictors on the Performance of 30-Day Readmission Risk Prediction Models.
  5. Systematic review of risk adjustment models of hospital length of stay (LOS).
  6. Assessing the effect of estimation error on risk-adjusted CUSUM chart performance.
  7. Outlier classification performance of risk adjustment methods when profiling multiple providers.
  8. Dynamic probability control limits for risk-adjusted CUSUM charts based on multiresponses.
  9. Revenues and expenses declined in 2011, but show increases when patient severity is considered.
  10. Multivariable risk prediction models: it's all about the performance.